Transformational EGFR Drug Discovery
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality globally.
Non-small-cell lung cancer (NSCLC) accounts for the majority of these cases (80−85%), and mutations in the kinase domain of the epidermal growth factor receptor (EGFR) are oncogenic drivers in a subset of this disease, adenocarcinoma.
Topics: Novel Therapeutics